OCUMENSION THERAPEUTICS financial statements, including revenue, expenses, profit, and loss
The total revenue of 1477 for the last semiannual is 181.64 M HKD, and it's 17.85% higher compared to the previous semiannual. The net income of H1 24 is -164.00 M HKD.